Burkitts lymfom er en højmalign tumor med en fordoblingstid på et døgn

Ulf Christian Frølund; Signe Ledou Nielsen; Per Boye Hansen

Burkitts lymfom er en højmalign tumor med en fordoblingstid på et døgn

Translated title of the contribution: Burkitt lymphoma is a highly malign tumour with a doubling time of twenty-four hours

Ulf Christian Frølund, Signe Ledou Nielsen, Per Boye Hansen

Research output: Contribution to journal › Journal article › Research › peer-review

4 Citations (Scopus)

Abstract

The treatment results for patients with Burkitt lymphoma have improved markedly over the past 20 years. Focus on the rapid doubling time of the lymphoma, and the frequent involvement of the central nervous system, have led to effective intensive chemotherapy regimens, where several of the drugs cross the blood-brain barrier. The overall survival is now 65-80% even when patients have advanced disease at the time of diagnosis. However, the condition and its complications such as tumour lysis syndrome are acute life threatening, and a quick diagnosis and proper management of complications are essential for the prognosis.

Translated title of the contribution	Burkitt lymphoma is a highly malign tumour with a doubling time of twenty-four hours
Original language	Danish
Journal	Ugeskrift for Laeger
Volume	173
Issue number	43
Pages (from-to)	2714-8
Number of pages	5
ISSN	0041-5782
Publication status	Published - 2011

Library access?

Check availability at the Royal Danish Library

Cite this

@article{92a5e5e92d2c4397a7ca3fd1a832ff60,

title = "Burkitts lymfom er en h{\o}jmalign tumor med en fordoblingstid p{\aa} et d{\o}gn",

abstract = "The treatment results for patients with Burkitt lymphoma have improved markedly over the past 20 years. Focus on the rapid doubling time of the lymphoma, and the frequent involvement of the central nervous system, have led to effective intensive chemotherapy regimens, where several of the drugs cross the blood-brain barrier. The overall survival is now 65-80% even when patients have advanced disease at the time of diagnosis. However, the condition and its complications such as tumour lysis syndrome are acute life threatening, and a quick diagnosis and proper management of complications are essential for the prognosis.",

author = "Fr{\o}lund, {Ulf Christian} and Nielsen, {Signe Ledou} and Hansen, {Per Boye}",

year = "2011",

language = "Dansk",

volume = "173",

pages = "2714--8",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "43",

}

TY - JOUR

T1 - Burkitts lymfom er en højmalign tumor med en fordoblingstid på et døgn

AU - Frølund, Ulf Christian

AU - Nielsen, Signe Ledou

AU - Hansen, Per Boye

PY - 2011

Y1 - 2011

N2 - The treatment results for patients with Burkitt lymphoma have improved markedly over the past 20 years. Focus on the rapid doubling time of the lymphoma, and the frequent involvement of the central nervous system, have led to effective intensive chemotherapy regimens, where several of the drugs cross the blood-brain barrier. The overall survival is now 65-80% even when patients have advanced disease at the time of diagnosis. However, the condition and its complications such as tumour lysis syndrome are acute life threatening, and a quick diagnosis and proper management of complications are essential for the prognosis.

AB - The treatment results for patients with Burkitt lymphoma have improved markedly over the past 20 years. Focus on the rapid doubling time of the lymphoma, and the frequent involvement of the central nervous system, have led to effective intensive chemotherapy regimens, where several of the drugs cross the blood-brain barrier. The overall survival is now 65-80% even when patients have advanced disease at the time of diagnosis. However, the condition and its complications such as tumour lysis syndrome are acute life threatening, and a quick diagnosis and proper management of complications are essential for the prognosis.

M3 - Tidsskriftartikel

SN - 0041-5782

VL - 173

SP - 2714

EP - 2718

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 43

ER -